GMAB Genmab A
Biotechnology NasdaqGS
Trading Signals (GMAB)
Overall Signal
SELL
Strong sellish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $19.1
- Medium Support $19.5
- Weak Support $19.9
Resistance Levels
- Weak Resistance $20.7
- Medium Resistance $21.1
- Strong Resistance $21.5
Stop Loss Suggestions
- Conservative $21.3
- Moderate $20.9
- Aggressive $21.3
Analyst Ratings
Current Rating
Last Month
2 Months Ago
3 Months Ago
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | SELL |
|
Short & Medium Term |
| Oscillators | SELL |
|
Short Term |
| Trend Indicators | SELL |
|
Short & Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (GMAB)
Quarterly Outlook :
2025-07-08
Bullish Scenario
from current 13.6%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (18.12) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (46.00) is in bearish territory, indicating downward momentum. MACD line (-0.29) is above Signal line (-0.48) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.38, indicating the average weekly price range.
2025-07-08
Base Scenario
from current 1.7%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (18.12) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (46.00) is in bearish territory, indicating downward momentum. MACD line (-0.29) is above Signal line (-0.48) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.38, indicating the average weekly price range.
2025-07-08
Bearish Scenario
from current -13.6%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (18.12) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (46.00) is in bearish territory, indicating downward momentum. MACD line (-0.29) is above Signal line (-0.48) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.38, indicating the average weekly price range.
Annual Outlook
2025-07-08
Bullish Scenario
from current 27.19%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (18.12) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (46.00) is in bearish territory, indicating downward momentum. MACD line (-0.29) is above Signal line (-0.48) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.38, indicating the average weekly price range.
2025-07-08
Base Scenario
from current 3.4%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (18.12) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (46.00) is in bearish territory, indicating downward momentum. MACD line (-0.29) is above Signal line (-0.48) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.38, indicating the average weekly price range.
2025-07-08
Bearish Scenario
from current -27.19%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (18.12) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (46.00) is in bearish territory, indicating downward momentum. MACD line (-0.29) is above Signal line (-0.48) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.38, indicating the average weekly price range.
Technical Analysis (GMAB)
Trend Identification
EMA
Exponential Moving Average
Current price (20.30) is below both Short MA (21.53) and Long MA (20.68). This indicates strong bearish momentum. Short MA (21.53) is above Long MA (20.68), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. MAs (21.53, 20.68, 20.75) show mixed alignment, suggesting market indecision or range-bound activity.
MACD
Moving Average Convergence Divergence
MACD line is below the Signal line (bearish crossover). This indicates downward momentum. Histogram (-0.2000) is negative and expanding, confirming bearish momentum. Both MACD and Signal lines are below the zero line, reinforcing bearish momentum (bearish territory). This is a strong sell signal. Consider short positions.
ADX
Average Directional Index
ADX (19.09) indicates a weak or non-existent trend (ranging market). -DI (32.72) is above +DI (22.32), suggesting a bearish directional bias. Avoid trend-following strategies. Consider range-bound or reversal strategies, or wait for a clearer trend to develop.
Momentum Measurement
RSI (2025-07-08)
Relative Strength Index
RSI (39.68) is in the bearish territory, but not yet oversold. This indicates downward momentum. Monitor for continuation or signs of strength.
OBV (2025-07-08)
On-Balance Volume
OBV (-915755.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-07-08)
Stochastic Oscillator
Stochastics (%K: 29.66, %D: 40.98) are in the neutral zone (between 20 and 80). A bearish crossover (%K below %D) is observed. This indicates downward momentum. Be cautious if it's already in the oversold region.
CCI (2025-07-08)
Commodity Channel Index
CCI (-76.61) is between -100 and 0. This indicates bearish momentum is present, but not yet extreme. A move below 0 from positive territory (bearish zero-line cross) can indicate a potential sell signal.
Volatility Measurement
ATR (2025-07-08)
Average True Range
Current ATR is 0.4700. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-07-08)
Volatility Bands
Current price (20.30) is within the Bollinger Bands (19.61 - 23.45). This suggests the price is trading within its typical volatility range. Price is below the Middle Band (21.53), indicating short-term bearish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals (GMAB)
SAR (2025-07-08)
Parabolic Stop and Reverse
SAR points above price indicate bearish trend. Current SAR at 21.30 is 4.93% from price. Consider SAR as a potential take-profit level or to confirm a downtrend.
Stochastic (2025-07-08)
Approaching Oversold
Stochastic is approaching oversold territory (29.7). No reversal signal yet. Monitor for potential bullish crossover (K above D) or entry into oversold (20-) followed by reversal. Current crossover status: Bearish.
RSI (2025-07-08)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-07-08)
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the lower half of the bands, suggesting a bearish bias.No indication of imminent volatility expansion or reversal.
Holder List Top 20 (GMAB)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Alliancebernstein L.P. | INSTITUTIONAL | 14725158 | 2.37% | 2025-03-31 |
| Orbis Allan Gray Ltd | INSTITUTIONAL | 5710741 | 0.92% | 2025-03-31 |
| Citadel Advisors Llc | INSTITUTIONAL | 4426654 | 0.71% | 2025-03-31 |
| AB LARGE CAP GROWTH FUND INC | MUTUALFUND | 4102116 | 0.66% | 2025-04-30 |
| Blackrock Inc. | INSTITUTIONAL | 3517852 | 0.57% | 2025-03-31 |
| iShares Trust-iShares Biotechnology ETF | MUTUALFUND | 2909918 | 0.47% | 2025-04-30 |
| Harding Loevner LLC | INSTITUTIONAL | 2880826 | 0.46% | 2025-03-31 |
| Morgan Stanley | INSTITUTIONAL | 2838928 | 0.46% | 2025-03-31 |
| Renaissance Technologies, LLC | INSTITUTIONAL | 2262350 | 0.36% | 2025-03-31 |
| Marshall Wace LLP | INSTITUTIONAL | 2181510 | 0.35% | 2025-03-31 |
| Two Sigma Advisers, LP | INSTITUTIONAL | 1973700 | 0.32% | 2025-03-31 |
| Two Sigma Investments, LP | INSTITUTIONAL | 1899766 | 0.31% | 2025-03-31 |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | MUTUALFUND | 1734584 | 0.28% | 2025-04-30 |
| RUSSELL INVESTMENT CO-Tax-Managed U.S. Large Cap Fund | MUTUALFUND | 508504 | 0.08% | 2025-04-30 |
| SUNAMERICA SERIES TRUST-SA AB Growth Portfolio | MUTUALFUND | 273260 | 0.04% | 2025-01-31 |
| Fidelity Covington Trust-Fidelity Enhanced International ETF | MUTUALFUND | 232236 | 0.04% | 2025-04-30 |
| LINCOLN Varbl INSURANCE Prod. TRT-LVIP AllianceBernstein Large Cap Gro | MUTUALFUND | 211782 | 0.03% | 2025-03-31 |
| American Century ETF Trust-Avantis International Equity ETF | MUTUALFUND | 186738 | 0.03% | 2025-04-30 |
| AB VARIABLE PRODUCTS SERIES FUND, INC.-AB Large Cap Growth Portfolio | MUTUALFUND | 147067 | 0.02% | 2025-04-30 |
| RUSSELL INVESTMENT CO-U.S. Strategic Equity Fund | MUTUALFUND | 138075 | 0.02% | 2025-04-30 |